Description: BICO Group AB (publ) operates as a bioconvergence company in North America, Europe, Asia, and internationally. It operates through three segments: Bioprinting, Biosciences, and Bioautomation. The Bioprinting segment offers products, solutions, and services that enable proliferation of 3D cell culture and 3D printing. The Biosciences segment provides instruments that enable the handling of cells and rare samples, and rapid transfer of liquids and reagents, as well as downstream analysis platforms. The Bioautomation segment offers end-to-end products and services in precision dispensing, advanced sample preparation, multiplex analysis and assay miniaturization, diagnostic and medical device manufacturing for life science and diagnostic industries. It primarily serves medical, pharmaceutical, and cosmetic industries. The company offers its products through sales organizations, as well as through an extensive distributor network. The company was formerly known as Cellink AB (publ) and changed its name to BICO Group AB (publ) in August 2021. BICO Group AB (publ) was incorporated in 2016 and is headquartered in Gothenburg, Sweden.
Home Page: www.bico.com
LAngfilsgatan 9
Gothenburg,
412 77
Sweden
Phone:
46 7 35 46 57 77
Officers
Name | Title |
---|---|
Ms. Maria Forss | President & CEO |
Mr. Jacob Thordenberg | Group Chief Financial Officer |
Mr. Marius Balger | Chief Operating Officer |
Ms. Asa Hillsten | Senior VP & Head of Investor Relations |
Andreas Joersjo | General Counsel |
Mr. Artur Aira | Head of Corporate Development and M&A |
Ms. Catharina Nordlund | Global Head of Human Resources |
Ms. Itedale Namro Redwan | Chief Scientific Officer - Bioprinting |
Niclas Emanuelsson | Head of Global Operations |
Dr. Holger Eickhoff Ph.D. | Senior VP & Business Area Director - Bioautomation |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
GIC Sector: | Health Care |
---|---|
GIC Group: | Health Care Equipment & Services |
GIC Industry: | Health Care Equipment & Supplies |
GIC Sub-Industry: | Health Care Equipment |
Forward PE: | 0 |
---|---|
Trailing PE: | 0 |
Price-to-Book MRQ: | 0.7788 |
Price-to-Sales TTM: | 0.0771 |
IPO Date: | |
Fiscal Year End: | August |
Full Time Employees: | 832 |